Binaprofen

苯胺洛芬

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NameBinaprofen
Drug Alias NameFelbinac Trometamol万舒安
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPostoperative inflammationOcular inflammationWounds and Injuries +[21] 
Global Approved IndicationsPain, Postoperative
Approved Indications in ChinaPain, Postoperative
Original Approved Country/TerritoryMainland China
Original Approved Date2026/01/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDalian Tianyu Pharmaceutical Co LtdShijiazhuang Yiling Pharmaceutical Co LtdGuangdong Zhongke Pharmaceutical Research Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShijiazhuang Yiling Pharmaceutical Co LtdGuangdong Zhongke Pharmaceutical Research Co LtdKivipharm Co Ltd +[4] 
Inactive CompaniesYiling Pharmaceutical Inc
Active IndicationsPostoperative inflammationWounds and InjuriesVisceral Pain +[16] 
Inactive IndicationsOcular inflammationCalculiUrinary Calculi +[5] 

Other Information

ATC CodeN/A
Related LinksN/A